E-cefotaxime,Cefotaxime Impurity D (EP)(65715-12-0)
- Name: E-cefotaxime,Cefotaxime Impurity D (EP)
- Synonyms:AZZMGZXNTDTSME-AAUIGXPGSA-M;sodium (6R,7R)-3-(acetoxymethyl)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;Cefotaxime EP Impurity D Sodium Salt;Cefotaxime Impurity 4(Cefotaxime EP Impurity D);E-cefotaxime,Cefotaxime Impurity D (EP);Cefotaxime EP Impurity D Sodium Salt (E-Cefotaxime Sodium Salt);Cefotaxime impurity 5/Cefotaxime EP Impurity D/E-Cefotaxime/(6R,7R)-3-[(acetyloxy)methyl]-7-[[(2E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Amino-Cefotaxime Sodium
- Molecular Formula:C16H17N5O7S2.Na
- Molecular Weight:478.46
- CAS Registry Number:65715-12-0
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 656815-39-3/4-{[(4-bromobenzyl)amino]methyl}benzoic acid
- 656816-06-7/2-[[cyclopentyl-[(3,4,5-trimethoxyphenyl)methyl]carbamothioyl]amino]acetic acid
- 656816-32-9/6-(4-Chlorobenzyl)-5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine
- 656817-41-3/5,7-dimethyl-6-(3-methylbenzyl)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid
- 656818-36-9/6-(2-fluorobenzyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxylic acid
- 656818-50-7/Methyl 5-(chloromethyl)-7-hydroxypyrazolo[1,5-a]-pyrimidine-3-carboxylate
- 656820-38-1/Methoxy-PEG-COOH average M.W. 2000
- 656825-93-3/Isoxazole, 3-[[[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]sulfinyl]-4,5-dihydro-5,5-dimethyl-
- 656831-86-6/2-(4-oxo-1-phenyl-1,4-dihydro-5H-pyrazolo[3,4-d]pyrimidin-5-yl)acetohydrazide
- 656836-87-2/2,4-Dichlorobenzo[d]oxazole
- 656837-36-4/Boron, [4-?ethyl-?2-?[(4-?ethyl-?3,?5-?dimethyl-?2H-?pyrrol-?2-?ylidene-?κN)?(4-?nitrophenyl)?methyl]?-?3,?5-?dimethyl-?1H-?pyrrolato-?κN]?difluoro-?, (T-?4)?-
- 65686-91-1/2,2,2-Trifluoro-1-(furan-2-yl)ethan-1-amine hydrochloride
- 65690-73-5/Ethyl 2-(3-amino-4-chlorophenyl)acetate(WX191517)
- 65690-74-6/Benzenepropanoic acid, 3-amino-4-chloro-, ethyl ester
- 6569-60-4/1,2,4-Oxadithiane
- 65697-23-6/2-Propenoic acid, 2-methyl-, polymer with ethenylbenzene and phenylmethyl 2-methyl-2-propenoate
- 65703-83-5/Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, compd. with 1-piperazineethanol (1:1) (9CI)
- 65703-84-6/Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, compd. with 1-methylpiperazine (1:1) (9CI)
- 6570-94-1/Pentane, 2-(bromomethyl)-3,4-dimethyl-
- 65715-12-0/E-cefotaxime,Cefotaxime Impurity D (EP)
- 6572-91-4/1,4-Dioxocane
- 657348-87-3/1,2-Benzisothiazol-3-amine, 6-(trifluoromethyl)-
- 657349-06-9/1H-1,2,4-Triazole-3-methanamine,N,N-diethyl-(9CI)
- 657350-40-8/4(3H)-Quinazolinone, 2-[[(2-aminophenyl)thio]methyl]-
- 657350-94-2/1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-(Theobroma grandiflorum acyl) derivs.
- 657363-19-4/2-Acetamido-1,3,6-tri-O-acetyl-6-azido-2,6-dideoxy-D-galactopyranose
- 657391-16-7/Benzenepropanamide, 4-fluoro-β-hydroxy-N-methyl-, (βR)-
- 657398-08-8/1H-Thieno[3,4-d]iMidazole-4-pentanaMide, N-[6-[(6-azidohexyl)aMino]-6-oxohexyl]hexahydro-2-oxo-, (3aS,4S,6aR)-
- 657398-10-2/1H-Thieno[3,4-d]iMidazole-4-pentanaMide, hexahydro-2-oxo-N-[6-oxo-6-(propylaMino)hexyl]-, (3aS,4S,6aR)-
- 657405-94-2/1-(1,1,3,3,6-pentamethyl-7-nitro-2,3-dihydro-1H-inden-5-yl)-1H-pyrrole